| Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) National Institutes of Health · PAR-27-015 | States, Counties, Cities & townships +12 | — | Nov 16, 2028 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-26-134 | States, Counties, Cities & townships +12 | — | Nov 22, 2028 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) National Institutes of Health · PA-26-001 | States, Counties, Cities & townships +12 | — | Nov 30, 2028 |
| Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) National Institutes of Health · PAR-27-067 | States, Counties, Cities & townships +12 | — | Jan 26, 2029 |
| Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) National Institutes of Health · PAR-27-024 | States, Counties, Cities & townships +12 | — | Jan 29, 2029 |
| Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) National Institutes of Health · PAR-27-032 | States, Counties, Cities & townships +12 | — | Feb 6, 2029 |
| BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) National Institutes of Health · RFA-NS-28-010 | States, Counties, Cities & townships +12 | $8.0M | Feb 8, 2029 |
| HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) National Institutes of Health · RFA-DA-27-016 | States, Counties, Cities & townships +12 | — | Feb 9, 2029 |
| HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) National Institutes of Health · RFA-NS-27-007 | States, Counties, Cities & townships +12 | $11.0M | Feb 20, 2029 |
| NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) National Institutes of Health · RFA-AR-28-001 | States, Counties, Cities & townships +12 | $17.0M | Mar 1, 2029 |
| Research Grants in Clinical Informatics (R01 Clinical Trial Optional) National Institutes of Health · PAR-26-042 | States, Counties, Cities & townships +12 | $2.5M | Mar 5, 2029 |
| Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) National Institutes of Health · PAR-26-040 | States, Counties, Cities & townships +12 | $2.5M | Mar 5, 2029 |
| NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required) National Institutes of Health · PAR-27-065 | States, Counties, Cities & townships +12 | — | Mar 9, 2029 |
| Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-025 | States, Counties, Cities & townships +12 | — | Mar 12, 2029 |
| Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) National Institutes of Health · PAS-27-028 | States, Counties, Cities & townships +12 | — | Mar 16, 2029 |
| NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) National Institutes of Health · PA-27-101 | Small businesses | — | Apr 5, 2029 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) National Institutes of Health · PAR-27-098 | States, Counties, Cities & townships +12 | — | Apr 5, 2029 |
| Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) National Institutes of Health · PA-27-037 | States, Counties, Cities & townships +10 | — | Apr 8, 2029 |
| NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-051 | States, Counties, Cities & townships +11 | — | Apr 17, 2029 |
| NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) National Institutes of Health · PA-27-036 | States, Counties, Cities & townships +12 | — | May 5, 2029 |
| NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) National Institutes of Health · PA-27-035 | States, Counties, Cities & townships +12 | — | May 5, 2029 |
| Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-111 | States, Counties, Cities & townships +12 | — | May 7, 2029 |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) National Institutes of Health · PA-26-002 | States, Counties, Cities & townships +12 | — | May 7, 2029 |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) National Institutes of Health · PAR-28-090 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| NIH Research Program Projects (Parent P01 Clinical Trial Optional) National Institutes of Health · PA-27-061 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed) National Institutes of Health · PAR-27-055 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) National Institutes of Health · PA-27-034 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-082 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-083 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) National Institutes of Health · PAR-27-077 | States, Counties, Cities & townships +12 | — | May 25, 2029 |
| Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed) National Institutes of Health · PAR-27-054 | Public universities, Nonprofits (501c3), Nonprofits (other) +2 | — | May 26, 2029 |
| Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional) National Institutes of Health · PAR-27-056 | States, Counties, Cities & townships +12 | — | May 30, 2029 |
| Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) National Institutes of Health · RFA-AI-27-018 | States, Counties, Cities & townships +12 | $7.0M | Jun 20, 2029 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) National Institutes of Health · PAR-27-064 | States, Counties, Cities & townships +12 | — | Jul 5, 2029 |
| NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-058 | States, Counties, Cities & townships +12 | — | Jul 5, 2029 |
| Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-057 | States, Counties, Cities & townships +12 | — | Jul 5, 2029 |
| Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) National Institutes of Health · PAR-27-073 | States, Counties, Cities & townships +12 | — | Jul 5, 2029 |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) National Institutes of Health · PAR-27-072 | States, Counties, Cities & townships +12 | — | Jul 5, 2029 |
| Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) National Institutes of Health · PA-27-030 | Public universities, Tribal governments, Tribal organizations +4 | — | Jul 12, 2029 |
| Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) National Institutes of Health · PAR-27-062 | States, Counties, Cities & townships +12 | — | Jul 12, 2029 |
| Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional) National Institutes of Health · PAR-28-093 | States, Counties, Cities & townships +12 | — | Jul 16, 2029 |
| Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed) National Institutes of Health · PAR-27-074 | States, Counties, Cities & townships +12 | — | Jul 16, 2029 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) National Institutes of Health · PAR-28-022 | States, Counties, Cities & townships +12 | $1.4M | Sep 25, 2029 |
| Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) National Institutes of Health · PAR-27-003 | States, Counties, Cities & townships +12 | — | Sep 26, 2029 |
| Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) National Institutes of Health · PAR-28-014 | States, Counties, Cities & townships +12 | — | Oct 11, 2029 |
| Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) National Institutes of Health · PAR-27-090 | States, Counties, Cities & townships +12 | — | Nov 5, 2029 |
| Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) National Institutes of Health · PAR-28-056 | States, Counties, Cities & townships +12 | — | Nov 5, 2029 |
| Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) National Institutes of Health · PAR-28-091 | States, Counties, Cities & townships +12 | — | Nov 16, 2029 |
| NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) National Institutes of Health · PAR-28-072 | States, Counties, Cities & townships +12 | — | Nov 16, 2029 |
| RFA-IP-18-000 Centers for Disease Control and Prevention - ERA · RFA-IP-18-000 | Others | — | Sep 30, 2030 |